Jason Romancik, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Astra Zeneca
    Topic:
    1st line treatment of CLL advisory board
    Date added:
    08/13/2024
    Date updated:
    08/13/2024
    Relationship end date:
    07/27/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    ADC Therapeutics
    Topic:
    Treatment of Relapsed/refractory DLBCL Ad board
    Date added:
    08/13/2024
    Date updated:
    08/13/2024
    Relationship end date:
    07/28/2023
Return to 2024 Wisconsin Multiple Myeloma & Lymphoma Summit